Skip to content

Microbot Medical MBOT Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$6.12M-2.6%$6.28M-6.6%$6.73M-11.7%$7.61M+10.0%$6.92M+4.4%
$5.31M+6.3%
-$16.04M-8.8%-$14.74M-5.0%-$14.04M-4.2%-$13.47M-9.9%-$12.26M-5.5%
$1.83M+42.4%$1.29M+98.0%$649K+44.2%$450K+64.8%$273K+50.0%
-$14.21M-8.1%-$13.14M-0.6%-$13.07M-2.8%-$12.71M-8.9%-$11.67M-2.0%
-$0.26+10.3%-$0.29+35.6%-$0.45+22.4%-$0.58+10.8%-$0.65+12.2%
-$16M-8.9%-$14.7M-5.2%-$13.97M-4.3%-$13.4M-10.0%-$12.18M-5.6%
-$16.04M-8.8%-$14.74M-5.0%-$14.04M-4.2%-$13.47M-9.9%-$12.26M-5.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Microbot Medical's revenue?
Microbot Medical (MBOT) generated $190.2K in revenue over the trailing twelve months, up 62.4% year over year.
Is Microbot Medical profitable?
Microbot Medical is not currently profitable: it reported a net loss of $14.2M over the trailing twelve months, a -3669.9% net margin.
What is Microbot Medical's earnings per share?
Microbot Medical's diluted EPS over the trailing twelve months is $-0.26.
Where does Microbot Medical's income statement data come from?
Every line is extracted from Microbot Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.